JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 54.7%

Neg 0% Neu 0% Pos 54.7%

JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.